Abstract
Objective
Originating from the pituitary gland, TSH secretion is regulated predominantly by thyroid-releasing hormone (TRH) neurons located in the hypothalamus. Norepinephrine and dopamine have important effects in modulation of TSH secretion. An inhibitor of catecholamine synthesis, α-methyl-para-tyrosine (AMPT) has been used in several studies of the regulation of human TSH secretion. The short-term effects (<8 hours) of low doses of AMPT include stimulation of pituitary TSH secretion by selective lowering of brain dopamine levels. After prolonged administration of AMPT (>24 hours), theoretically both dopamine and norepinephrine levels are lowered significantly in the brain, although this has not been reported previously.
Methods
Nine subjects (five women and four men) received a total of five 1-g doses of AMPT or five 50-mg doses of promethazine (active placebo) over 28 hours in a randomized, double-blind, placebo-controlled crossover design in which the active and control tests were separated by 4–6 weeks. Blood samples were obtained over 24 hours (18 time points) on day 2 of each condition.
Results
Changes in prolactin secretion and 6-hydroxymelatonin sulfate excretion indirectly showed the effects of AMPT on dopamine and norepinephrine. The typical circadian rhythm of TSH secretion was blunted by AMPT throughout the night; at ten time points, the difference between the two groups was statistically significant (P <. 01). The long-term effects of repeated doses of AMPT were inhibition of TSH secretion and significant attenuation of the circadian rhythm of TSH. Additionally, AMPT induced low norepinephrine levels, which counteracted the stimulatory effect of low dopamine levels on TSH.
Conclusions
Through its inhibitory effect on TRH, norepinephrine appeared to be involved in the regulation of TSH.
Similar content being viewed by others
References
Reichlin S. Neuroendocrinology. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders Company, 1998:165–248.
Sowers JR, Catania RA, Hershman JM. Evidence for dopaminergic control of circadian variations in thyrotropin secretion. J Clin Endocrinol Metab 1982;54:673–5.
Kerr DJ, Singh VK, McConway MG, et al. Circadian variation of thyrotrophin, determined by ultrasensitive immunoradiometric assay, and the effect of low dose nocturnal dopamine infusion. Clin Sci (Colch) 1987;72:737–41.
Boesgaard S, Hagen C, Hangaard J, Andersen AN, Eldrup E. Effect of dopamine and a dopamine D-l receptor agonist on pulsatile thyrotrophin secretion in normal women. Clin Endocrinol (Oxf) 1990;32:423–31.
Seki K, Nagata I. Effects of a dopamine antagonist (metoclopramide) on the release of LH, FSH, TSH and PRL in normal women throughout the menstrual cycle. Acta Endocrinol (Copenh) 1990;122:211–6.
Plosker SM, Rabinovici J, Montalvo M, Jaffe RB. Endogenous catecholamines suppress thyrotropin secretion during the early follicular phase of the menstrual cycle. J Clin Endocrinol Metab 1995;80:2530–3.
Woolf PD, Lee LA, Schalch DS. Adrenergic manipulation and thyrotropin releasing hormone (TRH)-induced thyrotropin (TSH) release. J Clin Endocrinol Metab 1972;35:616–8.
Nicoletti I, Filipponi P, Fedeli L, et al. Catecholamines and pituitary function. IV. Effects of low-dose dopamine infusion and long-term bromocriptine treatment on the abnormal thyrotroph (TSH) dynamics in patients with pathological hyperprolactinaemia. Acta Endocrinol (Copenh) 1986;111:154–61.
Engelman K, Horwitz D, Jéquier E, Sjoerdsma A. Biochemical and pharmacologic effects of a-methyltyrosine in man. J Clin Invest 1968;47:577–94.
Kitsikis A, Roberge AG. Behavioral and biochemical effects of alpha-methyltyrosine in cats. Psychopharmacologia 1973;31:143–55.
van Loon GR, Ho D, Kim C. Beta-endorphin-induced decrease in hypothalamic dopamine turnover. Endocrinology 1980;106:76–80.
Zimmermann RC, Krahn L, Klee G, Lu PY, Ory SJ, Lin SC. The impact of gender on alpha-methyl-para-tyrosine mediated changes in prolactin secretion and 6-hydroxymelatonin sulfate excretion. Psychoneuroendocrinology 1996;21:469–78.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
Delgado PL, Charney DS, Price LH, Landis H, Heninger GR. Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. Life Sci 1989;45:2323–32.
Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990;47:411–8.
Demisch L, Sielaff T, Gebhart P, Kaczmarczyk P, Blumenhofer A, Lemmer B. Melatonin secretion following tryptophan administration in healthy volunteers. Adv Pineal Res 1994;5:315–8.
Pontiroli AE, De Castro e Silva E, Mazzoleni F, et al. The effect of histamine and H1 and H2 receptors on prolactin and luteinizing hormone release in humans: Sex differences and the role of stress. J Clin Endocrinol Metab 1981;52:924–8.
Zimmermann RC, Krahn L, Klee G, Delgado P, Ory SJ, Lin SC. Inhibition of presynaptic catecholamine synthesis with alpha-methyl-para-tyrosine attenuates nocturnal melatonin secretion in humans. J Clin Endocrinol Metab 1994;79:1110–4.
Klee GG, Hay ID. Sensitive thyrotropin assays: Analytic and clinical performance criteria. Mayo Clin Proc 1988;63:1123–32.
Cricket graph users guide. Malvern, Pennsylvania: Cricket Software, 1986.
Sager S. StatView. Berkeley, California: Abacus Concepts, 1986.
Sager S. Superanova. Berkeley, California: Abacus Concepts, 1988.
Krulich L, Giachetti A, Marchlewska-Koj A, Hefco E, Jameson HE. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat. Endocrinology 1977;100:496–505.
Bunney WE Jr, Brodie HKH, Murphy DL, Goodwin FK. Studies of alpha-methyl-para-tyrosine, L-dopa, and L-tryptophan in depression and mania. Am J Psychiatry 1971;127:872–81.
Rossmanith WG, Mortola JF, Laughlin GA, Yen SS. Dopaminergic control of circadian and pulsatile pituitary thyrotropin release in women. J Clin Endocrinol Metab 1988;67:560–4.
Brodie HKH, Murphy DL, Goodwin FK, Bunney WE Jr. Catecholamines and mania: The effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism. Clin Pharmacol Ther 1971;12:218–24.
Grimm Y, Reichlin S. Thyrotropin releasing hormone (TRH): Neurotransmitter regulation of secretion by mouse hypothalamic tissue in vitro. Endocrinology 1973;93:626–31.
Hirooka Y, Hollander CS, Suzuki S, Ferdinand P, Juan SI. Somatostatin inhibits release of thyrotropin releasing factor from organ cultures of rat hypothalamus. Proc Natl Acad Sci U S A 1978;75:4509–13.
Fregly MJ. Activity of the hypothalamic-pituitary-thyroid axis during exposure to cold. Pharmacol Ther 1989;41:85–142.
Tuomisto J, Ranta T, Mannisto P, Saarinen A, Leppalioto J. Neurotransmitter control of thyrotropin secretion in the rat. Eur J Pharmacol 1975;30:221–9.
Author information
Authors and Affiliations
Additional information
Supported by a NARSAD (National Alliance for Research on Schizophrenia and Depression) Young Investigator Award (to RCZ).
The authors thank the clinical research staff of the Mayo General Clinical Research Center (NIH M01 00585), especially Jean M. Feehan, provided expert assistance. We thank Darlene L. Lucas, who performed the 6-hydroxymelatonin sulfate assay.
Rights and permissions
About this article
Cite this article
Zimmermann, R.C., Krahn, L.E., Klee, G.G. et al. Prolonged Inhibition of Presynaptic Catecholamine Synthesis With α-Methyl-Para-Tyrosine Attenuates the Circadian Rhythm of Human TSH Secretion. Reprod. Sci. 8, 174–178 (2001). https://doi.org/10.1177/107155760100800309
Published:
Issue Date:
DOI: https://doi.org/10.1177/107155760100800309